KRISTA MOORMAN: Open Payments
NPI 1982366993 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$788 in 38 payments from 14 companies in 2025. Trend: 2023 $922 · 2024 $1,480 · 2025 $788
Food & beverage: $788
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 14 | $250 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $115 |
| Novo Nordisk Inc | 4 | $85 |
| GENZYME CORPORATION | 2 | $51 |
| Hologic Sales and Service, LLC | 2 | $47 |
| SANOFI PASTEUR INC. | 2 | $41 |
| Lilly USA, LLC | 2 | $36 |
| Verity Pharmaceuticals Inc. | 1 | $33 |
| ViiV Healthcare Company | 1 | $29 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
Products named: XIFAXAN, DUPIXENT, APTIMA, Tlando, Saxenda, APRETUDE, ACCRUFER, BEYFORTUS.
Industry payments across CA — which companies pay providers there.
